Skip to content

Opioid-Free versus Opioid-Sparing Anesthesia for Postoperative Pain and Early Recovery After Laparoscopic Cholecystectomy: A Randomized Controlled Trial.

Miaomiao Xiong, Yao Liu, Yingsi Liang, Hailang Wang, Lili Zhang, Zhongjun Zhang, Ming Fang

Journal of pain research January 1, 2025 DOI: 10.2147/JPR.S506147 via PubMed

Summary

AI-generated from the abstract

Opioid-free anesthesia (OFA) is noninferior to opioid-sparing anesthesia (OSA) for managing pain after laparoscopic cholecystectomy, and it leads to faster bowel recovery. In a randomized controlled trial with 81 adults, pain scores over 36 hours were similar between groups (area under the curve 7.3 for OFA vs. 6.9 for OSA; the difference was 0.384, below the noninferiority threshold of 1.0). Although early pain in the first 12 hours after PACU discharge was slightly higher with OFA, overall pain control was sufficient in both groups. Bowel recovery occurred sooner with OFA (13.8 vs. 15.5 hours). Other outcomes, including hemodynamics and patient satisfaction, were comparable.

Study at a glance

Characteristics Randomized controlled trial Peer reviewed
Sample size 81
Population Adults undergoing laparoscopic cholecystectomy
Interventions dexmedetomidine propofol esketamine
Duration 36 hours postsurgery
Keywords Laparoscopic cholecystectomy Opioid-free anesthesia Opioid-sparing anesthesia Postoperative pain Randomized controlled trial
Citations 6
Key finding Opioid-free anesthesia is noninferior to opioid-sparing anesthesia in postoperative pain management and provides faster bowel recovery after laparoscopic cholecystectomy.

Abstract

Enhanced recovery after surgery emphasizes effective analgesia while minimal opioid use. Opioid-free anesthesia (OFA) and opioid-sparing anesthesia (OSA) have been shown to enhance recovery by reducing opioid-induced side effects. This study compared the efficacy of OFA and OSA in managing postoperative pain and recovery after laparoscopic cholecystectomy (LC). A single-center, randomized controlled trial was conducted with 86 adults undergoing LC. Patients received either OSA (sufentanil/remifentanil) or OFA (no opioids). Both groups received propofol, esketamine, dexmedetomidine, and erector spinae plane block. The primary outcome was pain area under the curve (AUCVAS) within 36 hours postsurgery. Secondary outcomes included hemodynamics, recovery times and bowel function. Eighty-one patients (41 and 40 in the OFA and OSA groups, respectively) completed the study. The AUCVAS scores were similar between the OFA (7.3 ± 1.4) and OSA (6.9 ± 1.3) groups (P = 0.201), the difference in AUCVAS between the two groups was 0.384 (95% CI: -0.296, 1.064), which was significantly below the preset noninferiority threshold of 1.0, demonstrating the noninferiority of OFA. While early pain scores within the first 12 hours postanesthesia care unit (PACU) discharge were slightly higher in the OFA group, but overall pain control was sufficient in both groups. The VAS scores from PACU discharge to 36 hours postoperatively, intraoperative hemodynamic variables, and the need for rescue analgesia were comparable. OFA patients experienced a faster bowel recovery (13.8 ± 2.4 vs 15.5 ± 2.3 hours, P = 0.002). Recovery times, postoperative QoR-40 scores, and patient satisfaction were similar between the groups. OFA is noninferior to OSA in pain management and hemodynamic stability, with faster bowel recovery after LC.

Comments

No comments yet.

Log in to comment